The Flowr Corporation (TSXV:FLWR) was featured in an article by Cantech Letter that discussed the company’s recent coverage by Clarus Securities. Within the Clarus report, analyst Noel Atkinson gave Flowr a speculative buy rating and one year price target of $5. He also highlighted some of the advantages that would make the company appealing to investors.

According to Atkinson, Flowr is one of a few Canadian licensed producers to successfully scale indoor cultivation of premium cannabis, which will allow them to meet consumer demands for premium cannabis. He also touched on the company’s experienced founding production team who have decades of collective experience in designing, building and optimizing indoor cultivation projects and are known for their success with Medreleaf’s facility in Markham, Ontario, which is still considered to be the gold standard for indoor cultivation in Canada.  Additionally, he also highlighted the supply agreements Flowr has with three provinces, including British Columbia and Ontario, and that they will be ramping up their revenues as the expansions underway at the company’s Kelowna campus go online.


To view the full article, click here.

Click here to connect with The Flowr Corporation (TSXV:FLWR) for an Investor Presentation.

Source: www.cantechletter.com

Ensuring estoraTMpatients have seamless access to their high-quality medical cannabis products

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announce that its subsidiary Pineapple Express Delivery Inc. (“Pineapple Express Delivery” or “PED”), a leading logistics technology company offering compliant and secure delivery of controlled substances and regulated products, has partnered with CannTrust Inc. to bring same-day and next-day delivery to estoraTM medical cannabis patients in Ontario

Keep reading... Show less

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less